The Patent Finder

Elira, Inc.

9 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 2, 2027
    The maintenance fee for Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions (US 10,335,302) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
  • 2 fees due Feb 1 to 13, 2027 · next Feb 1
  • 1 fee due Oct 16, 2027
    The maintenance fee for Glucose-based modulation of electrical stimulation to enable weight loss (US 11,957,895) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

PatentTitleStatus Expires Confidence
US D821,593Electro-dermal patch for use as a medical device
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,143,840Systems and Methods for Enabling Appetite Modulation And/Or Improving Dietary Compliance Using an Electro-Dermal Patch
In force
 · High confidence
In forceHigh confidence
US 11,957,895Glucose-based modulation of electrical stimulation to enable weight loss
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,335,302Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,154,922Systems and Methods for Enabling Appetite Modulation and/or Improving Dietary Compliance Using Percutaneous Electrical Neurostimulation
In force
 · Medium confidence
In forceMedium confidence
US 10,376,145Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,765,863Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,864,367Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,712,562Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 9: 5 lapsed for an unpaid fee · 1 past the fee grace period. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited